Your browser doesn't support javascript.
loading
The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential.
Michelfelder, Stefan; Fischer, Friedericke; Wäldin, Astrid; Hörle, Kim V; Pohl, Martin; Parsons, Juliana; Reski, Ralf; Decker, Eva L; Zipfel, Peter F; Skerka, Christine; Häffner, Karsten.
Afiliación
  • Michelfelder S; Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center, Faculty of Medicine.
  • Fischer F; Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center, Faculty of Medicine.
  • Wäldin A; Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center, Faculty of Medicine.
  • Hörle KV; Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center, Faculty of Medicine.
  • Pohl M; Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center, Faculty of Medicine.
  • Parsons J; Plant Biotechnology, Faculty of Biology, and.
  • Reski R; Plant Biotechnology, Faculty of Biology, and.
  • Decker EL; Centre for Biological Signaling Studies, University of Freiburg, Freiburg, Germany; and.
  • Zipfel PF; Plant Biotechnology, Faculty of Biology, and.
  • Skerka C; Leibniz Institute for Natural Product Research and Infection Biology, Friedrich Schiller University, Jena, Germany.
  • Häffner K; Leibniz Institute for Natural Product Research and Infection Biology, Friedrich Schiller University, Jena, Germany.
J Am Soc Nephrol ; 29(4): 1141-1153, 2018 04.
Article en En | MEDLINE | ID: mdl-29335241
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Proteínas Inactivadoras del Complemento C3b / Proteínas Sanguíneas / Inactivadores del Complemento / Terapia Molecular Dirigida / Síndrome Hemolítico Urémico Atípico Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Proteínas Inactivadoras del Complemento C3b / Proteínas Sanguíneas / Inactivadores del Complemento / Terapia Molecular Dirigida / Síndrome Hemolítico Urémico Atípico Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2018 Tipo del documento: Article